A Phase 1/2 Dose Escalation and Expansion Study of Cabiralizumab (cabira; FPA-008), an anti-CSF1R antibody, in Tenosynovial Giant Cell Tumor (TGCT, Diffuse Pigmented Villonodular Synovitis D-PVNS)
| Autor: | Kamalesh Sankhala, Jean-Yves Blay, Ganjoo, Kristen, Italiano, Antoine, Bass Hassan, Kim, Min, Ravi, Vinod, Cassier, Philippe, Rutkowski, Piotr, Sankar, Neil, Qazi, Ibrahim, Sikorski, Robert, Collins, Helen, Zhang, Charlie, Shocron, Ellyn, Gelderblom, Hans, Centre, Léon, Bérard, France, Maria |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| DOI: | 10.13140/rg.2.2.18553.16485 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|